Puma Biotechnology
PBYI
PBYI
154 hedge funds and large institutions have $3.1B invested in Puma Biotechnology in 2017 Q2 according to their latest regulatory filings, with 45 funds opening new positions, 48 increasing their positions, 48 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
3% more call options, than puts
Call options by funds: $130M | Put options by funds: $125M
0% more repeat investments, than reductions
Existing positions increased: 48 | Existing positions reduced: 48
6.65% less ownership
Funds ownership: 102.74% → 96.09% (-6.7%)
Holders
154
Holding in Top 10
6
Calls
$130M
Puts
$125M
Top Buyers
| 1 | +$200M | |
| 2 | +$162M | |
| 3 | +$64.1M | |
| 4 |
Millennium Management
New York
|
+$56.8M |
| 5 |
PHS
PFM Health Sciences
San Francisco,
California
|
+$53.9M |
Top Sellers
| 1 | -$204M | |
| 2 | -$89.2M | |
| 3 | -$75.6M | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$72.7M |
| 5 |
Schroder Investment Management Group
London,
United Kingdom
|
-$36.8M |